Oncomed Pharmaceuticals

Oncomed Pharmaceuticals company information, Employees & Contact Information

OncoMed Pharmaceuticals is a biotechnology company dedicated to improving cancer treatment by creating novel medicines that address the fundamental biologic pathways critical to tumor initiation, growth, metastases and recurrence. We are leveraging our understanding of cancer stem cell pathways and immuno-oncology targets to discover and develop novel therapeutics that could provide important alternatives for the treatment of cancer. OncoMed currently has seven internally discovered drug candidates in clinical development, as well as several active research programs undergoing preclinical evaluation. To support the advancement of our clinical-stage candidates and our continued discovery efforts, OncoMed has formed strategic alliances with Celgene Corporation, Bayer Pharma AG and GlaxoSmithKline. Since our founding in August 2004, we have raised more than $600 million, more than half of which has come from collaboration funding from our pharmaceutical partnerships.

Company Details

Employees
32
Founded
-
Address
800 Chesapeake Dr., Redwood City,ca 94063,united States
Phone
650-995-8200
Email
bd****@****med.com
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
HQ
Redwood City, CA
Looking for a particular Oncomed Pharmaceuticals employee's phone or email?

Oncomed Pharmaceuticals Questions

News

Lonza, OncoMed to Collaborate on Anti-Cancer Therapeutics - CHEManager

Lonza, OncoMed to Collaborate on Anti-Cancer Therapeutics CHEManager

Proposed Combination of Mereo BioPharma and OncoMed Pharmaceuticals - GlobeNewswire

Proposed Combination of Mereo BioPharma and OncoMed Pharmaceuticals GlobeNewswire

Wnt pathway inhibition via the targeting of Frizzled receptors results in decreased growth and tumorigenicity of human tumors - PNAS

Wnt pathway inhibition via the targeting of Frizzled receptors results in decreased growth and tumorigenicity of human tumors PNAS

OncoMed’s tarextumab fails to meet endpoints in Phase II trial for small-cell lung cancer - Clinical Trials Arena

OncoMed’s tarextumab fails to meet endpoints in Phase II trial for small-cell lung cancer Clinical Trials Arena

Newly merged Mereo BioPharma looks to OncoMed for R&D hires - Fierce Biotech

Newly merged Mereo BioPharma looks to OncoMed for R&D hires Fierce Biotech

OncoMed slammed by fizzled Bayer deal, Phase 2 failure - BioPharma Dive

OncoMed slammed by fizzled Bayer deal, Phase 2 failure BioPharma Dive

Beleaguered Bay Area Pharma OncoMed Lays Off Half Its Workforce - BioSpace

Beleaguered Bay Area Pharma OncoMed Lays Off Half Its Workforce BioSpace

Hard-to-Target WNT Pathway Gets a Fresh Look in Oncology - OncLive

Hard-to-Target WNT Pathway Gets a Fresh Look in Oncology OncLive

OncoMed Pharma To Reduce Its Workforce By About 50% - RTTNews

OncoMed Pharma To Reduce Its Workforce By About 50% RTTNews

OncoMed Halts Wnt Pathway Inhibitor Trials - drugdiscoverytrends.com

OncoMed Halts Wnt Pathway Inhibitor Trials drugdiscoverytrends.com

OncoMed Provides Update on Tarextumab Phase 2 Pancreatic Cancer ALPINE Trial - GlobeNewswire

OncoMed Provides Update on Tarextumab Phase 2 Pancreatic Cancer ALPINE Trial GlobeNewswire

Mereo BioPharma, OncoMed agree to merge - Pharmaceutical Business review -

Mereo BioPharma, OncoMed agree to merge Pharmaceutical Business review -

OncoMed’s Wnt-targeted experimental cancer drugs and bone-related adverse events - TLTC Blogs

OncoMed’s Wnt-targeted experimental cancer drugs and bone-related adverse events TLTC Blogs

Mereo officially cancels Nasdaq IPO as it closes in on OncoMed reverse merger - Fierce Biotech

Mereo officially cancels Nasdaq IPO as it closes in on OncoMed reverse merger Fierce Biotech

MorphoSys Q1 Profit Surges, Backs FY11 View; Gets Milestone Payment From OncoMed - RTTNews

MorphoSys Q1 Profit Surges, Backs FY11 View; Gets Milestone Payment From OncoMed RTTNews

Mereo BioPharma Group plc ("Mereo" or the "Company" or the - GlobeNewswire

Mereo BioPharma Group plc ("Mereo" or the "Company" or the GlobeNewswire

Top Oncomed Pharmaceuticals Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant